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ABSTRACT 
Objective:  
The primary objective of this study was to describe the epidemiology and management of 
dyspneic patients presenting to emergency departments (EDs) in an international patient 
population. Our secondary objective was to compare the EURODEM and AANZDEM patient 
populations. 
Methods: An observational prospective cohort study was performed in Europe and Asia-
Pacific region. The study included consecutive patients presenting to EDs with dyspnea as the 
main complaint. Data was collected on demographics, co-morbidities, chronic treatment, 
clinical signs and investigations, treatment in the ED, diagnosis, and disposition from ED.  
Results: A total of 5569 patients were included in the study. The most common ED diagnoses 
were  lower respiratory tract infection (LRTI) (24.9%), heart failure (HF) (17.3%), chronic 
obstructive pulmonary disease (COPD) exacerbation (15.8%) and asthma (10.5%) in the 
overall population. There were more LRTI, HF and COPD exacerbations in the EURODEM 
population whereas Asthma was more frequent in the AANZDEM population. Intensive care 
unit (ICU) admission rates were 5.5%. ED mortality was 0.6%. Overall in-hospital mortality 
was 5.0%. In hospital mortality rates were 8.7% for LRTI , 7.6% for HF and 5.6% for COPD 
patients. 
Conclusions: Dyspnea as a symptom in the ED has substantial ward and ICU admission 
rates. A variety of causes of dyspnea was observed in this study, with chronic diseases 
accounting for a major proportion. 
KEYWORDS: 
Dyspnea, emergency department, management, epidemiology, outcome 
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INTRODUCTION 
Dyspnea is one of the main complaints of patients presenting to the emergency department 
(ED)1. In the United States,  dyspnea accounts for 3 to 4 million ED visits annually2,3 
representing up to 50% of patients admitted to acute tertiary care hospitals4,5. In the Asia-
Pacific region it accounts for 5% of all ED presentations6. Diagnosis and treatment of the 
underlying cause of dyspnea is the most efficient approach to improve symptoms. However, 
establishing accurate diagnoses for ED dyspneic patients remains challenging. Sensitivity of 
the clinical signs associated with this symptom is low, especially in an aging population and 
the variety of underlying diseases7-10.  
Little is known about the etiology, epidemiology and outcome of dyspneic patients presenting 
to the EDs worldwide. Understanding patient characteristics, the range of diagnoses, outcome 
and regional differences could help improve emergency care of affected patients. 
Therefore, the primary objective of this study was to describe the epidemiology and 
management of dyspnea patients presenting to emergency departments (EDs) in an 
international patient population. Our secondary objective was to compare the EURODEM and 
AANZDEM patient populations. 
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METHODS 
Study design 
This is a combination of two international, multicenter, prospective, observational, cohort 
studies. They were designed to evaluate the epidemiology and outcomes of patients 
presenting to the ED with dyspnea as the main complaint. The EURODEM study 
(NCT02060799) was conducted in 66 European EDs in Belgium (n=3), Finland (n=5), France 
(n=5), Germany (n=5), Italy (n=1), the Netherlands (n=16), Romania (n=7), Spain (n=1), 
Turkey (n=7) and United Kingdom (n=16). The AANZDEM study was conducted in 46 Asia-
Pacific centers in Australia (n=33), New Zealand (n=4), Singapore (n=3), Hong Kong (n=4) 
and Malaysia (n=2). The study sample was generated with consecutive patients attending EDs 
during three study periods of 72 hours throughout one year. 6,11 European centers recruited 
patients during three consecutive days in February, May and October 2014, whereas inclusion 
dates for Australasian centers were in May, August and November. These dates were chosen 
to represent different seasons (autumn, winter and spring) in each region. 
Patient population 
Consecutive adult patients (18 years and older) presenting to the ED with acute dyspnea as 
the main symptom were included. The study was performed in accordance with the 
Declaration of Helsinki. Ethics committee approvals were obtained for all sites according to 
local requirements. If requested by the local ethics committee, patient consent for data 
collection was obtained.   
Study variables 
A specifically designed data collection form was developed by each steering committee (see 
Annex). Data collected included patient characteristics, co-morbidities, mode of arrival, usual 
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medications, prehospital treatment as documented in ED clinical records, initial assessment 
(clinical assessment and vital signs), investigations performed (laboratory tests, 
electrocardiogram (ECG), imaging, etc.) and results, treatment in the ED, ED diagnosis 
(diagnosis after ED management), outcome after the ED including disposition, in-hospital 
outcome and final hospital diagnosis.  
Outcomes of interest 
The primary outcome of interest was the proportion of patients in each etiologic category of 
dyspnea, their management at the ED and in-hospital mortality. Our secondary objective was 
to compare the characteristics of European patients’ (EURODEM study) to those of the Asia-
Pacific region (AANZDEM study). 
Statistical analysis 
Results are presented as frequencies for qualitative variables and as mean (stdev) or 
medians with interquartile range for quantitative variables depending on distribution. The 
chi-square test was used to compare categories. The means of continuous variables were 
compared using the t-test (parametric) and the Wilcoxon test (nonparametric). Statistical 
significance was defined as p < 0.05. Statistical analysis was performed using SAS version 
9.1 software (SAS Institute, Cary, NC, USA). 
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RESULTS 
Patient characteristics 
A total of 5569 patients were included in the study. Patient characteristics are summarized in 
table 1. Median age of patients was 68 [51-80] years and nearly half of the cohort were male. 
In approximately half of all cases, emergency physicians considered the cause of dyspnea to 
be of pulmonary origin and in a quarter of cases the cause of dyspnea was considered to be of 
cardiac origin. The most common ED diagnoses were lower respiratory tract infection 
(LRTI) (24.9%), heart failure (17.3%), COPD exacerbation (15.8%) and asthma (10.5%). A 
substantial proportion of patients had other diagnoses than the ones listed.  
The most frequent comorbidities were hypertension (46.9%), chronic obstructive pulmonary 
disease (COPD) (27.3%) and diabetes mellitus (23.0%). About half of patients presented to 
the ED by ambulance (49.3%).  
Vital and clinical signs at admission are summarized in table 2. Of all patients, 4.3% 
presented with confusion, 28.1% had signs of peripheral edema and 77.9% had abnormalities 
at lung auscultation (rales, wheezing or ronchi). A proportion of patients presented with vital 
signs indicating a severe clinical condition: 10% had tachycardia (heart rate > 120 bpm/min), 
13.6% had oxygen saturation below 90%, and 4.7% were hypotensive (systolic blood pressure 
< 100 mmHg). 
Management and outcomes 
Initial ED investigations are summarized in supplementary table 1. Supplementary Table 2 
describes treatment modalities at the EDs. The most commonly used medical therapies were 
inhaled β2 agonists (35.6%), antibiotics (29.5%) and corticosteroids (23.7%). 
Nearly two-thirds of the total study population were hospitalized after initial care at the ED. 
5.5% of patients were admitted to the ICU and 0.6% died in the ED. Overall in-hospital 
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mortality rate was 5.0%. In hospital mortality rates were 8.7% for LRTI, 7.6% for HF and 
5.6% for COPD patients. 
Regional differences 
The EURODEM patient population was slightly older than the AANZDEM cohort, median 
age 69 [53-80] years vs. 67 [49-80] years, (p=0.01).  
There were more LRTI, HF and COPD exacerbations in the EURODEM population whereas 
Asthma was more frequent in the AANZDEM population. EURODEM patients more often 
had a prior history of chronic heart failure, COPD, smoking and cognitive dysfunction.  
A higher ward admission rate was observed in Asia-Pacific than in Europe (60.6% vs. 56.4%, 
p<0.01). However, the proportions of ED deaths (0.9% vs. 0.4%, p=0.03) and intensive care 
unit (ICU) admissions (8.4% vs. 3.4%, p<0.001) were higher in the EURODEM cohort. In 
hospital mortality was also significantly higher in EURODEM compared to the AANZDEM 
cohort (6.5% vs. 4.1%, p<0.001). 
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DISCUSSION 
This study describes the epidemiology and contemporaneous management of dyspnea in EDs 
in Europe and Asia-Pacific region. Our results confirm that patients presenting to the ED with 
dyspnea represent a diverse and complex group. The most common causes of dyspnea in the 
ED were LRTI, decompensated (or acute) heart failure, COPD exacerbations and asthma.  
The high proportion of ‘other’ diagnoses (including unknown) is somewhat surprising and a 
salient reminder that the causes of  dyspnea are legion and that careful clinical assessment is 
required to differentiate between them. Importantly, our study demonstrates that dyspneic 
patients require immediate and high-quality care as the majority is admitted to hospital with 
not infrequent admissions to intensive care units13,14. This study emphasizes the challenges 
that ED physicians face while striving for accurate and prompt diagnosis and treatment. 
The most common diagnoses of dyspnea at the ED were LRTI, heart failure, COPD 
exacerbation and asthma. Our results seem to be in accordance with previous studies: Bilben 
and colleagues observed that COPD, cardiac failure, and pneumonia accounted for symptoms 
in 29, 24 and 22% of dyspneic ED patients respectively12. Even though lung and heart 
diseases were the main causes of dyspnea in the ED, it seems that a pulmonary origin 
(infection, COPD and asthma combined) was twice as common than a cardiac origin of 
dyspnea. This finding might help guide emergency physicians in cases where it is difficult to 
differentiate between both causes. 
The results of our study illustrate a diverse clinical profile of dyspneic patients at the ED in 
Europe compared to Asia-Pacific region. Dyspneic ED patients were mostly elderly, with 
25% of patients being older than 80 years. There is no gender predilection for this symptom. 
As expected in an elderly population, patients presented with many comorbidities. These 
concomitant illnesses can make it difficult to ascertain the specific diagnosis based on clinical 
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presentation in patients with dyspnea, and patients may have mixed disease contributing to the 
dyspnea.  
In both cohorts a significant proportion of patients presented with clinical signs suggesting a 
critical condition: tachycardia (10%), tachypnea (11%), low oxygen saturation (14%) and 
hypotension (5%). Therefore, high hospital admission rates as well as ICU admission and in-
hospital death were in line with disease severity.  
Our study confirms that dyspnea is a high risk condition for in-hospital mortality. We report 
in-hospital mortality of 5.0% which is similar to previously reported mortality rates in acute 
heart failure15, community acquired pneumonia16 and COPD exacerbations17. 
Our study shows that there were more ED deaths and ICU admissions in the EURODEM 
cohort. In-hospital mortality was also higher in Europe. This could be due to the increased 
frailty of EURODEM patients, suggested by their older age, higher rates of cognitive 
dysfunction and pre-existing chronic conditions. Differences in primary care provision might 
also account for these disparities.  
Our study has an important clinical impact for emergency physicians. It shows that acute 
management of dyspneic patients can be improved. It also highlights the need for an 
appropriate discharge analysis, as dyspnea at the ED was associated with a risk of ICU 
admission as well as in-hospital death. Our study also demonstrated that in the majority of 
cases, acute dyspnea was caused by an exacerbation of a pre-existing chronic condition. This 
emphasizes the importance of chronic disease management in primary care and outpatient 
settings, as preventing exacerbations of chronic heart failure or COPD could possibly reduce 
the burden of frequent ED visits and recurrent hospitalizations. 
Future research should be directed at understanding the source of the heterogeneities in 
patient characteristics as well as management differences between regions. Subsequent 
analyses are planned on subpopulations of the EURODEM and AANZDEM studies by 
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etiology of dyspnea. Future projects will include a more precise description of the four most 
frequent diseases causing dyspnea. We are also aiming to identify differences between the 
current real-life management of these diseases and treatment guidelines. 
LIMITATIONS 
Our study has several limitations. Since this was a multi-center registry, it should be taken 
into account that some centers recorded data differently than others. There was also no central 
committee for the establishment of final diagnosis or the appropriateness of administered 
treatment. One of the limitations of this work is that in the EURODEM study, it was allowed 
to include more than one diagnosis per patient whereas in the AANZDEM study only the 
principal diagnosis was collected.  However, study sample is large and presents all comers 
suggesting generalization of findings. Moreover, local data collectors had the possibility to 
contact the coordinating center if they had any queries regarding data collection therefore 
minimizing bias. There is also a certain amount of missing data that may have influenced 
results.   
CONCLUSION 
In summary, Dyspneic patients represent a heterogeneous group with a wide variety of 
clinical profiles and etiologies of dyspnea in both hemispheres. The population affected by 
this symptom is mostly elderly and have high rates of comorbidities. Exacerbations of chronic 
diseases such as heart failure and COPD account for a large proportion of dyspneic patients. 
Dyspnea at the ED was associated with a high rate of ward admission as well as sub-optimal 
short-term outcome. Our study also showed that the EURODEM patients were more ill than 
AANZDEM patients, presenting with more comorbidities and higher rates of ICU admission 
and hospital death. 
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Table 1: Patient characteristics 
Total AANZDEM EURODEM p value OR 
[95% CI] 
N (%) 5569 3044 (54.7%) 2525 (45.3%) 
Age (years), 
(median [Q1-Q3]) 
68 [51-80] 
missing data n= 25 
67 [49-80] 69 [53-80] 0.01 
Male (N, %) 2719 (49.0%) 
missing data n=21 
1495 (49.2%) 1224 (48.8%) NS 1.02 
[0.91-1.13] 
ED diagnoses (N, %) 
Lower respiratory 
tract infection 
1389 (24.9%) 616 (20.2%) 773 (30.6%) p<0.001 0.58 
[0.51-0.65] 
Heart failure 962 (17.3%) 455 (14.9%) 507 (20.1%) p<0.001 0.63 
[0.55-0.73] 
COPD exacerbation 882 (15.8%) 415 (13.6%) 467 (18.5%) p<0.001 0.70 
[0.60-0.81] 
Asthma 584 (10.5%) 387 (12.7%) 197 (7.8%) p<0.001 1.52 
[1.27-1.82] 
Other 2022 (36.3%) 1171 (38.5%) 851 (33.7%) p<0.001 1.24 
[1.10-1.38] 
Co-morbidities (N, %) 
Chronic heart failure 1102 (20.5%) 
missing data n=196 
522 (17.2%) 580 (24.7%) p<0.001 0.63 
[0.55-0.73] 
Diabetes mellitus 1246 (23.0%) 
missing data n=149 
697 (23.0%) 549 (22.9%) NS 1.01 
[0.89-1.14] 
Hypertension 2541 (46.9%) 
missing data n=152 
1405 (46.4%) 1136 (47.6%) NS 0.95 
[0.85-1.06] 
Atrial fibrillation / 
flutter  
873 (16.1%) 
missing data n=157 
468 (15.5%) 405 (17.0%) NS 0.90 
[0.77-1.04] 
COPD 1477 (27.3%) 
missing data n=164 
721 (23.9%) 756 (31.7%) p<0.001 0.67 
[0.60-0.76] 
Smoker 935 (17.9%) 
missing data n=336 
389 (12.9%) 546 (24.7%) 0.001 0.45 
[0.39-0.52] 
Asthma 1117 (20.6%) 
missing data n=143 
685 (22.6%) 432 (18.0%) 0.03 1.33 
[1.16-1.53] 
COPD: chronic obstructive pulmonary disease. 
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Table 2: Clinical signs at admission 
Total AANZDEM EURODEM p value OR 
[95% CI] 
Vital signs at admission 
SBP (mmHg), 
(median [Q1-Q3]) 
135 [120-154] 
missing data 
n=138 
136 [120-154] 135 [120-153] 0.21 
SBP<100mmHg (N, 
%) 
257 (4.7%) 141 (4.7%) 116 (4.7%) 0.01 1.01 
[0.78-1.31] 
Heart rate (bpm), 
(median [Q1-Q3]) 
90 [77-106] 
missing data 
n=115 
92 [78-106] 89 [77-105] p<0.001 
heart rate >120 bpm 
(N, %) 
547 (10.0%) 323 (10.8%) 224 (9.1%) 0.04 1.21 
[1.01-1.45] 
Respiratory rate 
(cycles/min), 
(median [Q1-Q3]) 
21 [18-26] 
missing data 
n=566 
22 [18-26] 20 [18-26] p<0.001 
Respiratory rate >30 
cycles/min (N, %) 
550 (11.0%) 334 (11.3%) 216 (10.5%) NS 1.09 
[0.90-1.31] 
SpO2 <90% (N, %) 685 (13.9%) 
missing data 
n=652 
308 (12.3%) 377 (15.7%) NS 0.75 
[0.64-0.89] 
Temperature <35 or 
>38° C (N, %)
477 (9.2%) 
missing data 
n=392 
282 (9.7%) 195 (8.6%) NS 1.14 
[0.94-1.39] 
Clinical signs at admission (N, %) 
Confusion 237 (4.3%) 
missing data 
n=96 
75 (2.5%) 162 (6.6%) p<0.001 0.36 
[0.27-0.48] 
Rales 1953 (37.4%) 
missing data 
n=346 
912 (31.5%) 1041 (44.7%) p<0.001 0.57 
[0.51-0.64] 
Wheezing 1220 (24.0%) 
missing data 
n=496 
590 (20.4%) 630 (28.9%) p<0.001 0.63 
[0.55-0.72] 
Rhonchi 826 (16.5%) 
missing data 
n=571 
280 (9.7%) 546 (25.9%) p<0.001 0.31 
[0.26-0.36] 
SBP: systolic blood pressure, SpO2: saturation level of oxygen in hemoglobin determined by 
pulse oximetry. 
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Supplementary table 1: diagnostic investigations at the ED 
Laboratory 
parameters 
at admission 
Total AANZDEM EuroDEM Mean 
difference 
[95%CI] 
p value 
Creatinine 
(μmol/L, 
median, Q1-
Q3) 
 82 (65-
110) 
performed 
n=3645 
(65.5%) 
83 (66-112) 79 (63-104) NA p<0.001 
Sodium 
(mmol/L, 
mean, std) 
 137.85 
(4.56) 
performed 
n=4587 
(82.4%) 
 137.72 (4.34) 137.99 (4.78) 0.28 
[0.01-0.54] 
0.04 
Potassium 
(mmol/L, 
mean, std) 
4.20 
(0.62) 
performed 
n=4469 
(80.2%) 
4.17 (0.61) 4.24 (0.64) 0.07 
[0.03-0.11] 
p<0.001 
CRP (mg/
dL, median, 
Q1-Q3) 
18 (5-70) 
performed 
n=2418 
(43.4%) 
30 (9-115) 13 (4-47) NA p<0.001 
PaCO2 
(mmHg, 
mean, std) 
41.36 
(16.85) 
performed 
n=1306 
(23.5%) 
46.62 (20.48) 38.20 (13.29) 8.42 
[6.58-
10.25] 
p<0.001 
White cell 
count 
(median, 
Q1-Q3) 
9.2 (7-12) 
performed 
n=3781 
(67.9%) 
9.1 (7-11.8) 9.25 (7-12.2) 0.64 [0.16-
1.12] 
0.01 
pH (mean, 
std) 
7.39 
(0.10) 
performed 
n=2302 
(41.3%) 
7.37 (0.11) 7.40 (0.09) 0.03 
[0.02-0.04] 
p<0.001 
D-dimer 
elevated 
(N,%)
301 
(55.4%) 
performed 
n=543 
56 (52.8%) 245 (56.1%) NA 
Supplementary Tables
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(9.8%) 
Haemoglobi
n (g/l, mean, 
std) 
12.72 
(2.61) 
performed 
n=4434 
(79.6%) 
12.58 (2.87) 12.72 (2.61) 0.31 
[0.16-0.47] 
p<0.001 
CRP: C-reactive protein. 
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Supplementary table 2: Management at the ED and outcomes 
Total AANZDEM EuroDEM p value OR 
[95% CI] 
Treatment in the ED (N, %) 
NIV 289 (5.2%) 
missing data 
n=201 
145 (4.8%) 144 (5.7%) NS 0.80 
[0.63-1.03] 
IV diuretics 1010 (18.6%) 
 missing data 
n=134 
468 (15.5%) 542 (22.5%) p<0.001 0.63 
[0.55-0.72] 
Oral diuretics 117 (3.4%) 
 missing data 
n=2146 
84 (2.8%) 33 (8.2%) p<0.001 0.32 
[0.21-0.50] 
IV vasodilators 200 (3.7%) 
 missing data 
n=149 
50 (1.7%) 150 (6.3%) p<0.001 0.25 
[0.18-0.35] 
Oral/sublingual 
vasodilators  
246 (7.8%) 
 missing data 
n=2434 
193 (6.4%) 53 (47.7%) p<0.001 0.07 
[0.05-0.11] 
IV inotropes/ 
vasopressors  
52 (1.0%) 
missing data 
n=169 
24 (0.8%) 28 (1.2%) NS 0.67 
[0.37-1.20] 
Antibiotics 1607 (29.5%) 
 missing data 
n=123 
938 (31.0%) 669 (27.6%) 0.01 1.18 
[1.04-1.33] 
Inhaled Beta-2 
agonists   
1941 (35.6%) 
 missing data 
n=110 
1019 (33.7%) 922 (37.9%) 0.02 0.83 
[0.74-0.93] 
Corticosteroids (IV 
or oral) 
1295 (23.7%) 
 missing data 
n=116 
762 (25.2%) 533 (22.0%) 0.01 1.19 
[1.05-1.36] 
Discharge from the ED (N, %) 
Home 2003 (36.8%) 
 missing data 
n=129 
1081 (35.6%) 922 (38.4%) 0.03 0.88 
[0.79-0.99] 
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    NIV: non-invasive ventilation, IV: intravenous. 
Ward 3118 (57.3%) 
 missing data 
n=129 
1843 (60.6%) 1275 (53.1%) p<0.001 1.36 
[1.22-1.52] 
Intensive care unit 283 (5.2%) 
 missing data 
n=129 
103 (3.4%) 180 (7.5%) p<0.001 0.43 
[0.33-0.56] 
Death in ED 36 (0.7%) 
 missing data 
n=129 
13 (0.4%) 23 (1.0%) 0.016 0.44 
[0.21-0.92] 
In hospital outcome (N, %) 
Mortality 254 (5.0%) 
 missing data 
n=535 
125 (4.1%) 129 (6.5%) p<0.05 0.62 
[0.48-0.80] 
This is a non-final version of an article published in final form in European Journal of Emergency Medicine, 26(5), 345-349. 
The final authenticated version is available online at: https://doi.org/10.1097/MEJ.0000000000000571
